GOLDMAN SACHS GROUP INC - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 44 filers reported holding AYTU BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q1 2022$54,000
-1.8%
50,146
+22.7%
0.00%
Q4 2021$55,000
-60.7%
40,867
-15.9%
0.00%
Q3 2021$140,000
+97.2%
48,593
+244.2%
0.00%
Q2 2021$71,000
-88.0%
14,118
-81.9%
0.00%
Q1 2021$592,00077,9580.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,398,776$8,365,0006.40%
ARMISTICE CAPITAL, LLC 1,333,334$7,973,0000.27%
PIPER SANDLER & CO. 49,590$297,0000.21%
SEARLE & CO. 14,000$84,0000.04%
WINTON GROUP Ltd 28,653$171,0000.01%
Squarepoint Ops LLC 34,862$208,0000.00%
BELLEVUE ASSET MANAGEMENT, LLC 260$2,0000.00%
Clearstead Advisors, LLC 1,421$8,0000.00%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 889$5,0000.00%
Ameritas Investment Partners, Inc. 202$1,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders